Phase 2 N=44 Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Esophageal or Gastroesophageal Junction Cancer
Esophageal Cancer
Primary: Determine Pathologic Complete Response — 9 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=43 VL vs DL in Inexperienced Users: a Pediatric Manikin Study
Videolaryngoscopes (VL) · Direct Laryngoscopy (DL) · Inexperienced Users
Primary: Time to Endotracheal Intubation — 72; 30; 72; 27 seconds
Phase 3 N=559 Efficacy and Safety Study of Certolizumab Pegol (CZP) Versus Active Comparator and Placebo in Subjects With Plaque Psoriasis (PSO)
Psoriasis · Plaque Psoriasis
Primary: Proportion of Subjects Who Achieve a Psoriasis Activity and Severity Index (PASI75) Response at Week 12 — 5.0; 53.3; 61.3; 66.7 percentage of participants — p=<0.0001
Phase 3 N=206 ENDEAVOUR: Phase 3 Multicenter Study of Revusiran (ALN-TTRSC) in Patients With Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC)
Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC) · Amyloidosis, Hereditary · Amyloid Neuropathies, Familial
Primary: 6 Minute Walk Distance (6-MWD)
Phase 2 N=271 Comparison of Anastrozole Verses Clomiphene Citrate in Stimulating Follicular Growth and Ovulation in Infertile Women With Ovulatory Dysfunction
Anovulation
Primary: Ovulation Rate in Cycle 1 — 64.9; 30.4; 36.8; 35.9 percentage of subjects
N/A N=99 fMRI Studies of Emotional Brain Circuitry in People With Major Depression
Depression
Primary: Activations in Different Cortical Regions Caused by Emotionally Evocative Task — -0.021; 0.084; 0.021; -0.030 Voxels
N/A N=130 Effect of Vitamin D3 on Vascular Function
Vitamin D Deficiency
Primary: Pulse Wave Velocity for Vascular Stiffness — 29.3; 27.6 m/s
Phase 2 N=17 Phase II Study of Tesetaxel in Metastatic Melanoma
Advanced Melanoma · Cancer
Primary: Response Rate (ie, the Percentage of Subjects With a Confirmed Complete or Partial Response) — 0; 0; 0; 0 percentage of participants
Phase 4 N=100 Effect of Neuromuscular Blockade on Pulmonary Complications in Elective Cardiac Surgery
Neuromuscular Blockade · Postoperative Complications
Primary: Number of Participants With Postoperative Pulmonary Complications — 8; 8 Participants — p=1.00
Phase 2 N=34 ProspectiveTrial of Proton Beam Combined With Anti-VEGF Therapy for Exudative Age-related Macular Degeneration (AMD)
Exudative Age-related Macular Degeneration
Primary: Percent of Eyes With Severe Ocular Adverse — 0; 0; 0 percentage of participants
Phase 3 N=102 Surgical Site Infections After Liver Transplantation Based on Perioperative Antibiotics
Liver Transplantation · Surgical Site Infection
Primary: Number of Subjects With Development of Surgical Site Infections — 9; 13 Participants
Phase 4 N=18 Detemir: Role in Type 1 Diabetes
Type 1 Diabetes Mellitus
Primary: Assess the Mean Area Under the Curve (AUC) for Blood Glucose Concentration in Subjects Treated With Either Insulin Detemir Mixed With Rapid Acting Insulin (RAI) or…
N/A N=134 A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
Peripheral Arterial Disease
Primary: Composite of Major Adverse Events (MAEs) — 2.3 percentage of subjects experiencing MAE — p=<0.001
Phase 2 N=21 Oral Nitrite for Older Heart Failure Patients
Heart Failure
Primary: Skeletal Muscle Bioenergetics- Polymerase Chain Reaction (PCR) — 12.04; 11.91; 11.79; 11.76 Relative Expression
Phase 3 N=546 Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
Esophageal Cancer · Gastric Cancer
Primary: Overall Survival — 3.6; 3.5 years